Mary Murphy, Principle Investigator, Remedi National University of Ireland Galway
Prof Norio Nakatsuji, Chief Advisor, Kyoto University
Jelena Ochs, Head of the Business Unit for Life Sciences Engineering, Fraunhofer Institute for Production Technology
Ioannis Papantoniou, ATMP Bioprocessing Coordinator, KU Leuven
Detlev Parow, Head of Department of Medicines, Therapeutic Appliances and Remedies, D.A.K.
Vivienne Parry, Head of Engagement, Genomics England
Sergey Piletsky, Professor, University of Leicester
Dr Qasim Rafiq, Associate Professor, Bioprocessing of Cell and Gene Therapies, University College London
Ajan Reginald, CEO, Celixir
Ajan Reginald is a co-founder and the Chief Executive Officer of Celixir, which he originally founded under the name Cell Therapy Ltd in 2009 with Nobel Laureate Professor Sir Martin Evans. Celixir is a British biotechnology company that discovers and develops life-saving and life-altering...
Benjamin Shepherd, Associate Director of R&D, Therapeutics, Organovo
Eric Soller, Vice President of Corporate Development & Strategy, BlueRock Therapeutics
Dr Frédéric Triebel, Chief Scientific Officer and Medical Officer, Prima Biomed, Ltd
Marc Turner, Medical Director, Scottish National Blood Transfusion Service
Dr Alain Vertes, Vice President, Alliance Manageement, NxR Biotechnologies
Dr Alain Vertès is a Sloan Fellow from London Business School and a microbiologist by training (University of Illinois at Urbana-Champaign, Institut Pasteur Paris, and University of Lille Flandres-Artois). He is a strategy and business development consultant for several companies, including big...